Nexgel Free Cash Flow Yield vs Days Payables Outstanding Analysis

NXGL Stock

USD 3.32 0.09 2.79%

Nexgel financial indicator trend analysis is infinitely more than just investigating Nexgel Inc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nexgel Inc is a good investment. Please check the relationship between Nexgel Free Cash Flow Yield and its Days Payables Outstanding accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexgel Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Free Cash Flow Yield vs Days Payables Outstanding

Free Cash Flow Yield vs Days Payables Outstanding Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nexgel Inc Free Cash Flow Yield account and Days Payables Outstanding. At this time, the significance of the direction appears to have no relationship.

The correlation between Nexgel's Free Cash Flow Yield and Days Payables Outstanding is 0.01. Overlapping area represents the amount of variation of Free Cash Flow Yield that can explain the historical movement of Days Payables Outstanding in the same time period over historical financial statements of Nexgel Inc, assuming nothing else is changed. The correlation between historical values of Nexgel's Free Cash Flow Yield and Days Payables Outstanding is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow Yield of Nexgel Inc are associated (or correlated) with its Days Payables Outstanding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Days Payables Outstanding has no effect on the direction of Free Cash Flow Yield i.e., Nexgel's Free Cash Flow Yield and Days Payables Outstanding go up and down completely randomly.

Correlation Coefficient

0.01

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Free Cash Flow Yield

A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.

Days Payables Outstanding

Most indicators from Nexgel's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nexgel Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexgel Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

The value of Selling General Administrative is expected to slide to about 2.6 M. The value of Issuance Of Capital Stock is estimated to slide to about 7.9 M

	2021	2022	2023	2024 (projected)
Total Revenue	1.6M	2.0M	4.1M	2.1M
Depreciation And Amortization	113K	301K	443K	266.2K

Total Revenue Depreciation And Amortization

Nexgel fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Total Liab	Total Current Assets	Common Stock	Other Liab	Net Tangible Assets	Other Assets	Property Plant Equipment	Net Invested Capital	Capital Stock	Non Current Liabilities Other	Net Working Capital	Short Long Term Debt Total	Current Deferred Revenue
Total Assets		0.43	0.88	0.98	0.89	0.37	0.71	-0.95	0.55	-0.1	0.85	0.49	0.44	0.85	0.98	-0.68	-0.59	0.94	-0.94	0.92	0.99	-0.79	-0.28	0.95	0.97	0.76
Other Current Liab	0.43		0.6	0.33	0.56	0.82	0.84	-0.47	0.91	-0.13	0.67	0.91	0.84	0.74	0.34	-0.39	-0.64	0.65	-0.55	0.47	0.4	-0.46	-0.89	0.3	0.59	0.43
Total Current Liabilities	0.88	0.6		0.77	0.88	0.61	0.77	-0.75	0.63	0.15	0.83	0.58	0.51	0.9	0.82	-0.73	-0.7	0.83	-0.8	0.88	0.82	-0.8	-0.39	0.72	0.92	0.82
Total Stockholder Equity	0.98	0.33	0.77		0.79	0.21	0.61	-0.94	0.44	-0.2	0.77	0.38	0.34	0.76	0.99	-0.58	-0.47	0.92	-0.9	0.83	0.99	-0.7	-0.19	0.99	0.93	0.72
Property Plant And Equipment Net	0.89	0.56	0.88	0.79		0.63	0.85	-0.88	0.72	0.02	0.91	0.7	0.57	0.88	0.79	-0.71	-0.68	0.86	-0.94	0.98	0.81	-0.86	-0.43	0.73	0.85	0.61
Accounts Payable	0.37	0.82	0.61	0.21	0.63		0.88	-0.42	0.9	0.21	0.77	0.91	0.82	0.79	0.25	-0.68	-0.85	0.55	-0.51	0.59	0.3	-0.73	-0.87	0.18	0.49	0.43
Non Current Assets Total	0.71	0.84	0.77	0.61	0.85	0.88		-0.78	0.96	0.01	0.95	0.95	0.83	0.95	0.62	-0.72	-0.83	0.86	-0.82	0.83	0.67	-0.85	-0.83	0.58	0.78	0.6
Non Currrent Assets Other	-0.95	-0.47	-0.75	-0.94	-0.88	-0.42	-0.78		-0.64	0.19	-0.89	-0.61	-0.57	-0.84	-0.93	0.68	0.62	-0.96	0.98	-0.91	-0.94	0.79	0.4	-0.93	-0.9	-0.63
Net Receivables	0.55	0.91	0.63	0.44	0.72	0.9	0.96	-0.64		-0.14	0.85	0.99	0.9	0.84	0.44	-0.6	-0.78	0.76	-0.71	0.67	0.5	-0.7	-0.92	0.41	0.64	0.41
Common Stock Shares Outstanding	-0.1	-0.13	0.15	-0.2	0.02	0.21	0.01	0.19	-0.14		0.04	-0.08	-0.17	0.08	-0.14	-0.28	-0.19	-0.22	0.19	0.09	-0.14	-0.2	0.11	-0.22	-0.07	0.38
Non Current Liabilities Total	0.85	0.67	0.83	0.77	0.91	0.77	0.95	-0.89	0.85	0.04		0.82	0.75	0.98	0.78	-0.85	-0.87	0.92	-0.9	0.93	0.82	-0.95	-0.67	0.75	0.87	0.71
Inventory	0.49	0.91	0.58	0.38	0.7	0.91	0.95	-0.61	0.99	-0.08	0.82		0.91	0.81	0.38	-0.57	-0.77	0.71	-0.68	0.64	0.44	-0.67	-0.92	0.35	0.58	0.37
Other Current Assets	0.44	0.84	0.51	0.34	0.57	0.82	0.83	-0.57	0.9	-0.17	0.75	0.91		0.73	0.35	-0.64	-0.84	0.65	-0.64	0.54	0.41	-0.6	-0.85	0.33	0.53	0.29
Total Liab	0.85	0.74	0.9	0.76	0.88	0.79	0.95	-0.84	0.84	0.08	0.98	0.81	0.73		0.78	-0.82	-0.86	0.92	-0.86	0.89	0.82	-0.91	-0.69	0.74	0.91	0.79
Total Current Assets	0.98	0.34	0.82	0.99	0.79	0.25	0.62	-0.93	0.44	-0.14	0.78	0.38	0.35	0.78		-0.63	-0.52	0.92	-0.88	0.84	1.0	-0.72	-0.2	0.99	0.95	0.77
Common Stock	-0.68	-0.39	-0.73	-0.58	-0.71	-0.68	-0.72	0.68	-0.6	-0.28	-0.85	-0.57	-0.64	-0.82	-0.63		0.94	-0.68	0.68	-0.8	-0.65	0.93	0.45	-0.58	-0.69	-0.65
Other Liab	-0.59	-0.64	-0.7	-0.47	-0.68	-0.85	-0.83	0.62	-0.78	-0.19	-0.87	-0.77	-0.84	-0.86	-0.52	0.94		-0.69	0.65	-0.73	-0.56	0.87	0.7	-0.46	-0.65	-0.58
Net Tangible Assets	0.94	0.65	0.83	0.92	0.86	0.55	0.86	-0.96	0.76	-0.22	0.92	0.71	0.65	0.92	0.92	-0.68	-0.69		-0.95	0.87	0.94	-0.8	-0.56	0.9	0.96	0.71
Other Assets	-0.94	-0.55	-0.8	-0.9	-0.94	-0.51	-0.82	0.98	-0.71	0.19	-0.9	-0.68	-0.64	-0.86	-0.88	0.68	0.65	-0.95		-0.94	-0.9	0.8	0.44	-0.86	-0.89	-0.58
Property Plant Equipment	0.92	0.47	0.88	0.83	0.98	0.59	0.83	-0.91	0.67	0.09	0.93	0.64	0.54	0.89	0.84	-0.8	-0.73	0.87	-0.94		0.85	-0.92	-0.38	0.78	0.87	0.68
Net Invested Capital	0.99	0.4	0.82	0.99	0.81	0.3	0.67	-0.94	0.5	-0.14	0.82	0.44	0.41	0.82	1.0	-0.65	-0.56	0.94	-0.9	0.85		-0.75	-0.27	0.99	0.96	0.79
Capital Stock	-0.79	-0.46	-0.8	-0.7	-0.86	-0.73	-0.85	0.79	-0.7	-0.2	-0.95	-0.67	-0.6	-0.91	-0.72	0.93	0.87	-0.8	0.8	-0.92	-0.75		0.52	-0.68	-0.78	-0.69
Non Current Liabilities Other	-0.28	-0.89	-0.39	-0.19	-0.43	-0.87	-0.83	0.4	-0.92	0.11	-0.67	-0.92	-0.85	-0.69	-0.2	0.45	0.7	-0.56	0.44	-0.38	-0.27	0.52		-0.19	-0.43	-0.32
Net Working Capital	0.95	0.3	0.72	0.99	0.73	0.18	0.58	-0.93	0.41	-0.22	0.75	0.35	0.33	0.74	0.99	-0.58	-0.46	0.9	-0.86	0.78	0.99	-0.68	-0.19		0.91	0.72
Short Long Term Debt Total	0.97	0.59	0.92	0.93	0.85	0.49	0.78	-0.9	0.64	-0.07	0.87	0.58	0.53	0.91	0.95	-0.69	-0.65	0.96	-0.89	0.87	0.96	-0.78	-0.43	0.91		0.84
Current Deferred Revenue	0.76	0.43	0.82	0.72	0.61	0.43	0.6	-0.63	0.41	0.38	0.71	0.37	0.29	0.79	0.77	-0.65	-0.58	0.71	-0.58	0.68	0.79	-0.69	-0.32	0.72	0.84

Click cells to compare fundamentals

Nexgel Account Relationship Matchups

Nexgel fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.9M	2.3M	17.0M	10.4M	10.0M	6.1M
Other Current Liab	69K	213K	380K	113K	738K	774.9K
Total Current Liabilities	800K	1.3M	2.9M	859K	2.5M	1.3M
Total Stockholder Equity	380K	71K	12.1M	7.6M	4.7M	3.7M
Property Plant And Equipment Net	1.2M	1.4M	2.6M	2.5M	3.4M	1.7M
Accounts Payable	510K	658K	254K	265K	1.2M	1.3M
Non Current Assets Total	1.4M	1.9M	3.1M	2.9M	4.9M	5.1M
Net Receivables	102K	73K	209K	222K	633K	664.7K
Common Stock Shares Outstanding	13.6M	104.3M	5.6M	5.6M	5.7M	5.4M
Liabilities And Stockholders Equity	1.9M	2.3M	17.0M	10.4M	10.0M	6.1M
Non Current Liabilities Total	710K	854K	2.0M	1.9M	2.2M	2.4M
Inventory	113K	233K	291K	502K	1.3M	1.4M
Total Liab	1.5M	2.2M	4.9M	2.7M	4.8M	5.0M
Total Current Assets	513K	363K	13.9M	7.5M	5.1M	3.9M
Common Stock	281K	57K	99K	6K	5.4K	5.1K
Net Tangible Assets	380K	(287K)	11.7M	7.3M	8.4M	8.8M
Property Plant Equipment	1.2M	1.4M	2.6M	2.5M	2.8M	1.5M
Net Invested Capital	380K	543K	14.4M	7.9M	5.5M	5.3M
Net Working Capital	(287K)	(969K)	11.0M	6.6M	2.5M	3.5M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Nexgel Inc is a strong investment it is important to analyze Nexgel's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nexgel's future performance. For an informed investment choice regarding Nexgel Stock, refer to the following important reports:

How To Invest In Nexgel

Details

Is Nexgel Stock a good investment?

Details

What is Nexgel's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nexgel Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexgel. If investors know Nexgel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nexgel listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.59)

Revenue Per Share

0.846

Quarterly Revenue Growth

0.234

Return On Assets

(0.23)

Return On Equity

(0.64)

The market value of Nexgel Inc is measured differently than its book value, which is the value of Nexgel that is recorded on the company's balance sheet. Investors also form their own opinion of Nexgel's value that differs from its market value or its book value, called intrinsic value, which is Nexgel's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nexgel's market value can be influenced by many factors that don't directly affect Nexgel's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Nexgel's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexgel is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexgel's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Nexgel Free Cash Flow Yield vs Days Payables Outstanding Analysis

Free Cash Flow Yield vs Days Payables Outstanding

Free Cash Flow Yield vs Days Payables Outstanding Correlation Analysis

Correlation Coefficient

Free Cash Flow Yield

Days Payables Outstanding

Nexgel fundamental ratios Correlations

Nexgel Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Nexgel fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Invested Capital	+ 1.0	Total Current Assets
Net Invested Capital	+ 0.99	Total Assets
Total Current Assets	+ 0.99	Total Stockholder Equity
Net Invested Capital	+ 0.99	Total Stockholder Equity
Net Working Capital	+ 0.99	Total Stockholder Equity
Inventory	+ 0.99	Net Receivables

Net Tangible Assets	- 0.96	Non Currrent Assets Other
Other Assets	- 0.95	Net Tangible Assets
Capital Stock	- 0.95	Non Current Liabilities Total
Non Currrent Assets Other	- 0.95	Total Assets
Property Plant Equipment	- 0.94	Other Assets
Net Invested Capital	- 0.94	Non Currrent Assets Other